Revolutionising Therapies for Neurological Diseases
Healthy Ageing and Growing-up Healthy
SMDG is developing safe, innovative, disease-modifying and life-saving therapies for some of the most debilitating diseases our societies face today. SMDG's team has focused on neurodegenerative diseases and paediatric neurological disorders as the first diseases to tackle. We do this by utilising our ground breaking and transformative platforms for targeted and safe delivery of therapies and genetic medicines and broad understanding of these diseases for designing first in-class therapeutics.
Our
Story
Get to Know Us
SMDG is an award-winning and pioneering biotechnology company developing novel, safe and effective therapies for most debilitating diseases. We are a team of internationally renowned scientists who have been recognised globally for their work in drug delivery. And we are innovators and entrepreneurs with extensive experience in studying nature of different diseases and designing innovative therapeutics utilising the latest technologies. We have embarked on an ambitious path of designing better disease modifying and First-in-Class therapies that are safe for patients and are good for the environment. The science of nanotherapeutics is at the beginning stages of creating realistic, effective and safe therapies and we are at the forefront of this field.
SMDG is an award-winning biotechnology company, recognised for its groundbreaking therapeutic platforms. Join us on our mission to transform the lives of patients suffering from neurological diseases and other debilitating diseases. Together, we can make a difference.
Dr Farhangrazi recognised as a 2024 CEO of the year leading a life sciences company by the SME News